A molecular scoring system (IPSS-M) was recently proposed for myelodysplastic syndrome (MDS). We conducted a retrospective study of adults with MDS referred 2019-2021. The primary outcomes were leukemia-free survival (LFS) and overall survival (OS). One hundred and forty-four patients diagnosed ...
Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines clinical par
POSTER: MDS-266 A Comprehensive Assessment of the Molecular International Prognostic Scoring System (IPSS-M) and Other Molecularly Integrated Risk Stratification Models in Chronic Myelomonocytic Leukemia (CMML)doi:10.1016/S2152-2650(23)00585-2Luis E. Aguirre MD...
However, few risk signatures which integrate the revised international prognostic scoring system (IPSS-R) with gene mutations can be easily applied in the real world. Methods The training cohort of 63 MDS patients was conducted at Zhongda Hospital of Southeast University from January 2013 to April ...
However, according to the Revised International Prognostic Scoring System (IPSS-R), the der(7)t(1;7) presents an intermediate prognosis. To report cases of patients with MDS who presented the unbalanced translocations der(7)t(1;7) and their clinical outcomes. This study included 4 patients ...
2.4. Internal Prognostic Scoring System (IPSS) Given the imprecision of classification with regard to clinical outcomes, the International Prognostic Scoring System (IPSS) MDS prognostication system was created for primary untreated MDS (Table 2) [10,11,12]. Two refinements of this model have been...